New eye drug shows promise in battle against blinding disease
Disease control
Completed
This study tested a new medicine called LUBT010 against a standard treatment (Lucentis) for wet age-related macular degeneration, a leading cause of vision loss. About 600 adults aged 50 and older received monthly eye injections for one year. The main goal was to see if LUBT010 w…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Disease control
Last updated May 17, 2026 11:57 UTC